About Meduna's pioneer activity.
Fink
Max
M
D000241:Adenosine / Q000266:history* / Q000627:therapeutic use; D000493:Allopurinol / Q000266:history* / Q000627:therapeutic use; D002314:Cardioplegic Solutions / Q000266:history* / Q000627:therapeutic use; D004565:Electroconvulsive Therapy / Q000266:history*; D005060:Europe; D005978:Glutathione / Q000266:history* / Q000627:therapeutic use; D049673:History, 20th Century; D006801:Humans; D007328:Insulin / Q000266:history* / Q000627:therapeutic use; D009426:Netherlands; D019188:Organ Preservation Solutions; D010506:Periodicals as Topic / Q000266:history; D011570:Psychiatry / Q000266:history*; D011887:Raffinose / Q000266:history* / Q000627:therapeutic use; D012640:Seizures / Q000266:history; D017211:Treatment Failure; D014481:United States
D002314:Cardioplegic Solutions; D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose